Summary
Latest filing:
Dan Benjamin Teleman is Chief Executive Officer, Director of Nasus Pharma Ltd (NSRX). 4 SEC Form 4 filings on record, most recently on 29 July 2026. Most recent open-market trade: bought $20K of NSRX on 22 June 2026. Lifetime open-market purchases: $62K.
Recent Transactions
3Every recent SEC Form 4 transaction Dan Benjamin Teleman has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Dan Benjamin Teleman's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Scilex Holding Co - $200.00M of SMNR open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $199.99M of TYRA open-market activity in the last 12 months
- Catalyst4, Inc. - $191.21M of MPLT open-market activity in the last 12 months
- John Oyler - $189.61M of ONC open-market activity in the last 12 months
- Michael Benkowitz - $174.13M of UTHR open-market activity in the last 12 months
- BVF PARTNERS L P - $173.67M of KYMR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Dan Benjamin Teleman?
Dan Benjamin Teleman is a corporate insider, tracked as Chief Executive Officer, Director of Nasus Pharma Ltd (NSRX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Dan Benjamin Teleman submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Dan Benjamin Teleman been buying or selling stock?
Recorded transactions: 3 open-market purchases ($62K) and 0 open-market sales across all tracked filings.
Where can I see all of Dan Benjamin Teleman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Dan Benjamin Teleman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
